膀胱电切术后膀胱灌注吡柔比星预防腺性膀胱炎复发的疗效分析
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:


The effectiveness of intravesical instillation of pirarubicin after transurethral resection for preventing recurrence of cystitis glandularis
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    目的 探讨腺性膀胱炎电切术后应用吡柔比星膀胱内灌注化疗预防复发的疗效.方法 87例病理证实的腺性膀胱炎患者,44例经尿道电切术后行吡柔比星膀胱内灌注(A组),43例仅单纯电切治疗(B组),比较两组患者术后复发率及观察吡柔比星膀胱内灌注副反应.结果 随访3~54个月,平均36个月,A组7例复发,B组14例复发,两组总复发率比较差异有统计学意义(P<0.05).吡柔比星主要副作用为尿频、尿急、尿痛等膀胱刺激症状.结论 腺性膀胱炎电切术后应用吡柔比星膀胱内灌注能明显减少腺件膀胱炎电切术后复发,且副反应少,安全性较高.

    Abstract:

    Objectives To evaluate the therapeutic effect of intravesical I~ustillation of pirarabicin (THP)in the cystitis glandularis after transurethral resection. Methods of 87 cases of pathological proven cystitis glan-dularis ,44 cases were managed by intravesical instillation of pirarubiein after transurethral resection (group A) ,and the remaining 43 cases were not subjected to any drug after transurethrai resection (group B) . The recurrent rate and side effects between two groups were compared. Results After follow-up for 36 months (6-54 months) , there were 7 cases and 14 cases of recurrence in group A and group B respectively. There was significant difference in the recurrent rate between two groups (p < 0.05) . The side effects of pirarubicin occurred in 3 cases of group A :urinary frequency , urgency ,edynuria. Conclusions lntravesical instillation of piraruhiein after transurethral re-section can significantly decrease the rerurrence of cystitis glandularis ,and the incidence of side effects was lower.

    参考文献
    相似文献
    引证文献

引用格式: 齐飞波,王乾,马乐,王英刚,闵立贵.膀胱电切术后膀胱灌注吡柔比星预防腺性膀胱炎复发的疗效分析[J].国际泌尿系统杂志,2009,(2).

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数: